Carotid stenting: the preferred management for carotid atherosclerosis?
Cerebrovascular morbidity and mortality continue to be a matter of concern to the cardiologists besides adding to the healthcare cost the world over. Carotid atherosclerosis, which has long been managed successfully with carotid endarterectomy, is on the verge of being unpopular with advent of carotid artery stenting, particularly with developments in distal embolic protection devices. This article reviews the findings of several trials on carotid stenting as also their limitations.
Rajagopal
Vivek
V
Cleveland Clinic Foundation, Department of Cardiovascular Medicine, Cleveland, Ohio 44195, USA.
Yadav
Jay S
JS
D002340:Carotid Artery Diseases / Q000601:surgery / Q000628:therapy*; D000077144:Clopidogrel; D016894:Endarterectomy, Carotid; D005374:Filtration; D006801:Humans; D009203:Myocardial Infarction / Q000453:epidemiology; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D019736:Prostheses and Implants; D016032:Randomized Controlled Trials as Topic; D015607:Stents; D020521:Stroke / Q000453:epidemiology / Q000517:prevention & control; D013988:Ticlopidine / Q000031:analogs & derivatives / Q000627:therapeutic use; D016896:Treatment Outcome
D010975:Platelet Aggregation Inhibitors; D000077144:Clopidogrel; D013988:Ticlopidine